Dose-Response: An International Journal
Volume 8 | Issue 4

Article 9

12-2010

EXPOSURE TO NANOPARTICLES AND
HORMESIS
Ivo Iavicoli
InstituCatholic University of Sacred Heart, Italy

Edward J Calabrese
University of Massachusetts, Amherst, MA

Marc A Nascarella
Gradient, USA

Follow this and additional works at: https://scholarworks.umass.edu/dose_response
Recommended Citation
Iavicoli, Ivo; Calabrese, Edward J; and Nascarella, Marc A (2010) "EXPOSURE TO NANOPARTICLES AND HORMESIS," DoseResponse: An International Journal: Vol. 8 : Iss. 4 , Article 9.
Available at: https://scholarworks.umass.edu/dose_response/vol8/iss4/9

This Article is brought to you for free and open access by ScholarWorks@UMass Amherst. It has been accepted for inclusion in Dose-Response: An
International Journal by an authorized editor of ScholarWorks@UMass Amherst. For more information, please contact
scholarworks@library.umass.edu.

Iavicoli et al.: Exposure to Nanoparticles and Hormesis

Dose-Response, 8:501–517, 2010
Formerly Nonlinearity in Biology, Toxicology, and Medicine
Copyright © 2010 University of Massachusetts
ISSN: 1559-3258
DOI: 10.2203/dose-response.10-016.Iavicoli

EXPOSURE TO NANOPARTICLES AND HORMESIS
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Heart, School of Medicine, Italy
Edward J. Calabrese
Public Health, USA
Marc A. Nascarella

䊐

䊐

University of Massachusetts Amherst, Department of
Gradient, USA

䊐 Nanoparticles are particles with lengths that range from 1 to 100 nm. They are increasingly being manufactured and used for commercial purpose because of their novel and
unique physicochemical properties. Although nanotechnology-based products are generally thought to be at a pre-competitive stage, an increasing number of products and materials are becoming commercially available. Human exposure to nanoparticles is therefore
inevitable as they become more widely used and, as a result, nanotoxicology research is
now gaining attention. However, there are many uncertainties as to whether the unique
properties of nanoparticles also pose occupational health risks. These uncertainties arise
because of gaps in knowledge about the factors that are essential for predicting health
risks such as routes of exposure, distribution, accumulation, excretion and dose-response
relationship of the nanoparticles. In particular, uncertainty remains with regard to the
nature of the dose-response curve at low level exposures below the toxic threshold. In fact,
in the literature, some studies that investigated the biological effects of nanoparticles,
observed a hormetic dose-response. However, currently available data regarding this topic
are extremely limited and fragmentary. It therefore seems clear that future studies need
to focus on this issue by studying the potential adverse health effects caused by low-level
exposures to nanoparticles.

Key words: nanoparticles, hormesis, health effects.

INTRODUCTION

Nanotechnology is an emerging multidisciplinary science that
involves applications based upon the synthesis of molecules in the
nanoscale (10–9 m) size range. This technology has the ability to manipulate matter on a near-atomic scale to produce new structures, materials
and devices with unique physical and chemical properties (NIOSH 2009).
These characteristics enhance versatility and efficacy in product development, resulting in more effective industrial and medical applications,
concomitant with the production of more versatile and efficacious products (Colvin 2003). Consequently, nanotechnology has the potential to
dramatically improve the effectiveness of a number of existing consumer
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and industrial products and could have a substantial impact on the development of new products in all sectors, ranging from disease diagnosis and
treatment to environmental remediation (NIOSH 2009). In fact, research
in nanoscale technologies is growing rapidly worldwide and the National
Science Foundation (NSF 2001) estimates that, by 2015, nanotechnology
will have a $1 trillion impact on the global economy and will employ 2
million workers, 1 million of whom may be in the United States while Lux
Research (2007) predicts that new emerging nanotechnology applications will affect nearly every type of manufactured product through the
middle of the next decade, becoming incorporated into 15 % of global
manufacturing output and totalling $2.6 trillion in 2014.
According to ISO/TS 27687 (ISO 2008), a nano-object is defined as
material with one, two, or three external dimensions in the size range
from approximately 1–100 nm. Subcategories of nano-objects are
nanoplate, a nano-object with one external dimension at the nanoscale,
nanofiber, a nano-object with two external dimensions at the nanoscale
with a nanotube defined as a hollow nanofiber and a nanorod as a solid
nanofiber and nanoparticle, a nano-object with all three external dimensions at the nanoscale. Nano-objects are commonly incorporated in a
larger matrix or substrate referred to as a nanomaterial.
Reducing particle size increases surface area and modifies unique
physicochemical properties such as high conductivity, strength, durability, and chemical reactivity (Nel et al. 2006). For these reasons, the industrial applications of nanomaterials are very wide-ranging and include
those that may lead to more efficient water purification, stronger and
lighter building materials, increased computing power and speed,
improved generation and conservation of energy and new tools for the
diagnosis and treatment of diseases (Card et al. 2008). The latest update
of the nanotechnology consumer product inventory, maintained by the
Project on Emerging Nanotechnologies (PEN), includes over 1,000 products, and has grown nearly 4-fold since it was established in March 2006
(PEN 2009). However, the PEN database does not evaluate whether a
product truly contains nanoparticles, it simply reports manufacturer
claims, hence the number of nanoenabled products is probably lower.
Nonetheless, new nanotechnology consumer products are coming on the
market at the rate of three to four per week (PEN 2008). In fact, silica
(SiO2) nanoparticles are used as biomarkers for leukaemia cell identification (Santra et al. 2001), cancer therapy (Hirsch et al. 2003), drug delivery (Venkatesan et al. 2005) and they also find extensive applications in
chemical mechanical polishing and as additives to drugs, cosmetics, printer toners, varnishes and food (Lin et al. 2006). Metal nanoparticles such
as cerium oxide nanoparticles have wide-ranging applications for solar
and fuel cells, gas sensors, abrasives for chemical mechanical planarizations, oxygen pumps, metallurgic, glass and ceramic applications (Zheng
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et al. 2005; Gao et al. 2006); titanium dioxide, in nanoparticle form, is one
of the most important materials for photocatalysts, paints, sterilization,
bio-medical ceramic and implanted biomaterials, cosmetics and pharmaceuticals (Gelis et al. 2003; Sun et al. 2004); silver nanoparticles are used
in bedding, washers, water purification, toothpaste, shampoo and rinse,
infant nipples and nursing bottles, fabrics, deodorants, filters, kitchen
utensils, toys and humidifiers (Maynard 2006). Finally, carbon nanotubes
(CNTs) are currently of interest for a variety of applications in electronics, reinforced rods, micro-fabricating conjugated polymer activators,
biosensors and enhanced electron/scanning microscopy imaging techniques (Shvedova et al. 2009).
The increase in nanoparticle applications has led to an increase in
concern about their potential human toxicity and their environmental
impact. Indeed, as a result of their small size and unique physicochemical properties, the toxicological profiles of nanoparticles may differ considerably from those of larger particles composed of the same materials
(Borm et al. 2006; Nel et al. 2006). Consequently, in the last few years, nanotoxicology has emerged in order to clarify the relationship between the
physical and chemical properties (eg. size, shape, surface chemistry, composition, aggregation and surface area) of nanomaterials and the induction of toxic biological responses (Lynch et al. 2006). In the literature,
most of the studies, that have addressed this topic have focused their
attention on the adverse effects of nanoparticles on the respiratory system (Mitchell et al. 2007; Park et al. 2008, 2009; Wang et al. 2008; Sung et
al. 2009). However, when inhaled nanoparticles are deposited in lung
cells and translocated through epithelial and endothelial cells into the
blood and lymph circulation, they may reach potentially sensitive target
sites including bone marrow, lymph nodes, spleen, heart and central
nervous system. Several studies have also investigated the toxic effects of
nanoparticles on other organs and systems (Lai et al. 2008; Belyanskaya et
al. 2009; Legramante et al. 2009; Murray et al. 2009; Sharma et al. 2009;
Simeonova and Erdely 2009). Nevertheless, there is a general lack of
information concerning the effects of manufactured nanomaterials on
human health and the environment and, in particular, uncertainty
remains with regard to the nature of the dose-response curve for low level
exposures. Furthermore, since these studies investigated the toxic effects
of different nanoparticles of the same compound, the results reported for
a particular type of nanomaterial cannot be considered representative of
the whole class. In fact, nanoparticles of the same compound can have
different toxicological profiles because of differences in the chemical
composition, in the aggregation and surface area, in the shape or size. All
of these factors can affect the dose-response relationship.
Hormesis is a dose-response relationship characterized by a low-dose
stimulation and a high-dose inhibition (Eaton and Klaassen 2001). The
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hormetic dose response has been typically represented in graphs as an
inverted U- or J-shaped dose response, depending on the endpoint measured. For example, in the cases of growth, cell proliferation, memory and
longevity, hormetic responses have typically been graphed as an inverted
U-shaped dose response. In the case of endpoints such as disease incidence (e.g., tumour formation, cardiovascular disease, genotoxicity, birth
defects), hormetic effects are typically graphed as a J-shaped dose
response. However, this broad range of inverted U- and J-shaped dose
response relationships are all considered examples of hormesis
(Calabrese 2009).
In this review we have explored the possible presence of hormesis in
the studies that have investigated the adverse health effects of nanoparticles.
IN VITRO STUDIES

In the literature there are some in vitro toxicological studies (Table 1)
that reported a hormetic dose-response following exposure to nanoparticles, in particular carbon nanotubes, quantum dots, metal nanoparticles.
The molecular mechanisms underlying the pathological behaviour of
carbon nanotubes (CNTs) were investigated and observed in several in
vivo and in vitro studies. The results obtained by Pulskamp et al. (2007a)
are particularly interesting in relation to the purpose of our review. In this
study, human alveolar epithelial cells A549 were exposed at various concentrations (5-100 µg/ml) of different CNT preparations (NT1-AP, the
most impure form; NT2-AT, free of carbonaceous materials and markedly reduced in metal content; NT2-DMF, free of carbonaceous materials
but still with high levels of metals) to elicit oxidative stress response. The
NT1-AP were commercially purchased (Nanostructured and Amorphous
Materials Inc.) and were synthesized using chemical vapour deposition.
The NT2-DMF were obtained from NT2 (synthesized by means of the
laser vaporization method using graphite targets doped with equal parts
of Ni and Co) after purification and separation from the amorphous carbon-containing preparations using DMF (N, N-dimethyl formamide).
Finally, NT2-AT were obtained from NT2-DMF after acid treatment with
HNO3 to yield a purified version with reduced catalyst concentrations.
Before use in the experiment, the CNTs were precipitated in acetone and
resuspended in bidistilled water, sedimented again by centrifugation, and
finally added to growth media and diluted to the final concentrations.
Prior to use, the samples were sonicated and vigorously mixed to break
up the nanotube bundles and sediments. To keep the sample preparations free from other disturbing chemical additives like DMSO or SDS
(which facilitate CNT dispersion), a certain degree of CNT aggregation
was accepted in the sample fluid. In order to determine oxidative stress,
cultured cells were assayed for short-term incubation of 10 minutes as
504
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Single Walled Carbon Nano
Tubes

Single Walled Carbon Nano
Tubes

(TGA)-capped CdTe Quantum
Dots and TGA-capped CdTe
Quantum Dots produced in
the presence of gelatin

Quantum Dots, with a core
material of indium gallium
phosphide

Silver, molybdenum and
aluminium nanoparticles

Silver nanoparticles

To assess CNTs toxicity and
pathology

To assess CNTs toxicity and
pathology

To explore the possibility of
building a high – content, high
– throughput cytotoxicity assay
platform based on high –
content screening technology to
meet the demands for
nanotoxicity studies.

To assess the cytotoxicity of
different types quantum dots

To assess the suitability of a
spermatogonial stem cell line as
a model for the assessment of
nanotoxicity

To study the potential cytotoxic
effects of silver nanoparticles

Continued

Type of nanoparticles

Aim of the study

TABLE 1. In vitro studies that showed a hormetic dose - response

Peripheral
blood
mononuclear
cells PBMCs

Spermatogonia
l stem cell line
C18-4

Porcine renal
proximal
tubule cell line
LLC-PK1

NG108-15
murine
neuroblastoma
cells

Rat alveolar
macrophage
cell line
NR8383

Human
alveolar
epithelial cell
line A549

Type of cells

1 – 30 ppm

5 – 100 µg/ml

4 – 1000 nM

0 – 100 nM

5 – 100 µg/ml

5 – 100 µg/ml

Range of
concentrations

Low dose stimulation and high dose
inhibition of cell proliferation

Low dose stimulation and high dose
inhibition of mitochondrial function and
cell viability

Low dose stimulation and high dose
inhibition of cell viability

Increase in total neurite length at lower
concentrations and inhibition of neurite
outgrowth at higher concentrations

Low dose stimulation and high dose
inhibition of cell viability

Biphasic oxidative burst

Hormetic response

Shin et al.
(2007)

BraydichStolle et al.
(2005)

Stern et al.
(2008)

Jan et al.
(2008)

Pulskamp et
al. (2007b)

Pulskamp et
al. (2007a)

References
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Paclitaxel-loaded in sterically
stabilized, biocompatible and
biodegradable sterically
stabilized mixed phospholipid
nanomicelles (P-SSMM)

To assess efficacy of paclitaxelloaded in P-SSMM and P-DMSO
in circumventing the Pglycoprotein-mediated
paclitaxel resistance

Silver nanoparticles

To investigate the potential
toxic effects of silver
nanoparticles

Graphite nanofibers

Silver nanoparticles

To study the cellular responses
Continued
of two different cell lines
exposed to silver nanoparticles

To evaluate the cytotoxicity and
genotoxicity of graphite
nanofibers

Type of nanoparticles

Aim of the study

TABLE 1. Continued

Human breast
cancer cell line
BC19/3

Human
bronchial
epithelial cells
BEAS 2B

Human
hepatoma
derived cell
line HepG2

Human skin
carcinoma cell
line A431 and
human
fibrosarcoma
cell line HT1080

Type of cells

0.128 – 2000
ng/ml

1 – 100 µg/cm2

0.1 – 3 mg/L

0.39 – 25 µg/ml

Range of
concentrations

Low dose stimulation and high dose
inhibition of cell viability

Low dose stimulation and high dose
inhibition of cell viability

Low dose stimulation and high dose
inhibition of cell viability

In A431 cells induction of caspase-3
production at concentrations in the range
of 1.56 – 6.25 µg/ml and inhibition, at
concentrations ≤ 0.78 and ≥ 12.5 µg/ml.
In HT-1080 cells induction of caspase-3
production at concentrations in the range
of 0.78 – 6.25 µg/ml ml and inhibition, at
concentrations ≤ 0.39 and ≥ 12.5 µg/

Hormetic response

Önyüksel et
al. (2009)

Lindberg et
al. (2009).

Kawata et al.
(2009).

Arora et al.
(2008)
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well as for an extended period of 24 hours. Data provided by this work
showed that the NT2-AT did not elicit reactive oxygen species (ROS),
while NT2-DMF caused a significant increase in ROS production after
only 24 hours and finally the most impure form of CNTs induced an
increase in ROS after 10 minutes and 24 hours. Moreover, NT1-AP
showed a stimulation of ROS production at 5 and 10 µg/ml, while the
ROS levels decreased at 50 and 100 µg/ml.
The same author (Pulskamp et al. 2007b) studied, in the rat alveolar
macrophage cell line NR8383, the cytotoxic effects caused by exposure to
different types of commercially available CNTs. Viability of the cells treated with 5, 10, 50 and 100 µg/ml of nanoparticles was evaluated using the
3-[4, 5-dimethyl-2-thiazolyl]-2, 5-diphenyl -2H- tetrazolium bromide
(MTT) test and the 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium (WST-1) assay. Results of the MTT test showed
a dose-dependent decrease in cell viability but, surprisingly, data of the
WST-1 test did not agree with the MTT test and they did not indicate a
loss of viability due to exposure to all kinds of CNTs. Furthermore, at
lower concentrations, in the WST-1 assay, an increase in viability was
observed, which rather suggested an increase in proliferation upon particle stimulation. These findings revealed a low-dose stimulation and a
high-dose inhibition that could be explained by the presence of the
hormetic phenomenon.
Jan et al. (2008) explored the possibility of building a high-content,
high-throughput cytotoxicity assay platform based on high-content
screening technology to meet the demands for nanotoxicity studies. In
this attempt they carried out several experiments using differentiated and
undifferentiated NG108-15 murine neuroblastoma cells and HepG2
human hepatocyte carcinoma cells exposed to cadmium telluride quantum dots (CdTe QDs) and to gold nanoparticles, respectively. In particular, NG108-15 murine neuroblastoma cells were exposed to thioglycolic
acid (TGA)-capped CdTe QDs (TGA-QD) and to a TGA-capped CdTe QD
produced in the presence of gelatin (Gelatin-QD). Both of these QDs had
a diameter of 3 nm. To investigate the different toxicological effects of
TGA-QD and of Gelatin-QD, a neurite outgrowth assay was used. The
results showed that a 6-hour treatment with 25 nM of TGA-QDs prior to
neuronal differentiation reduced the total neurite length by approximately 50 %. However, treatment with 25 nM of Gelatin QDs led to a
slight increase in total neurite length. This difference was most evident at
the 50 nM dose of exposure, where all TGA-QD treated cells were killed
while Gelatin-QD treated cells still exhibited some viability and a moderate level of neurite outgrowth. The authors suggested that this contradictory effect at low dose could be a hormetic response, as hormesis is frequently observed as a result of low-dose stimulation in toxicological studies. In fact, the mechanisms involved in countering the cytotoxic effect of
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a short, non lethal low-dose treatment might have stimulated the formation of neurites.
Stern et al. (2008) studied the toxic effects of another type of QDs,
with a core material of indium gallium phosphide (InGaP-QDs), on
porcine renal proximal tubule cell line (LLC-PK1) treated for 24 and 48
h with concentrations of InGaP-QDs in the range of 4 – 1000 nM.
Cytotoxicity of this nanomaterial was determined by the MTT assay and,
in the 24h experiment, the results showed an important loss of cell viability at concentrations exceeding 100 nM. Surprisingly, exposure of LLCPK1 to doses of InGaP-QDs in the range of 30 – 80 nM caused a significant increase in cell viability. Therefore, these results showed the presence of a hormetic dose-response.
In 2005, Braydich-Stolle et al. (2005) assessed the toxicity of metal
nanoparticles in the male germ line. The authors exposed the spermatogonial stem cell line C18-4 to silver (Ag-NPs, 15 nm in diameter), molybdenum (Mo-NPs, 30 nm in diameter) and aluminium nanoparticles (30
nm in diameter), dispersed in phosphate buffered saline, at concentrations in the range of 5 – 100 µg/ml. The evaluation of the germline stem
cell mitochondrial function and viability, after treatment with Mo-NPs,
showed the presence of a hormetic-like biphasic dose response. In fact,
the results of this study indicated that, in the C18-4 cell line, Mo-NPs exert
toxic effects on cellular metabolic activity at concentrations of 50 µg/ml
and above whereas, at low doses (5 – 25 µg/ml), they stimulate the mitochondrial function.
Another example of hormesis was observed in a subsequent study that
investigated the potential cytotoxicity, the effects on the production of
cytokines by and on the proliferation of peripheral blood mononuclear
cells (PBMCs) exposed for 72 h to 1, 3, 5, 10, 20 and 30 ppm of Ag-NPs
(Shin et al. 2007). The cytotoxic effects of these nanoparticles were evaluated using an aqueous cell proliferation assay and a 5-chloromethylfluorescein diacetate (CMFDA) assay. Results showed a dose-response relationship characterized by a low-dose stimulation and a high-dose inhibition. In fact, cell proliferation was found to be significantly decreased at
Ag-NPs concentrations exceeding 15 ppm whereas, at lower doses an
important stimulatory effect was observed.
Spherical silver nanoparticles of 7 – 20 nm in diameter were also used,
as colloidal aqueous suspension, by Arora et al. (2008) to study the cellular responses of the cell lines A431 (human skin carcinoma) and HT-1080
(human fibrosarcoma) exposed to different concentrations of Ag-NPs.
Particularly interesting was the effect of these nanoparticles on caspase-3
activity. In fact, in A431 cells, Ag-NPs induce caspase-3 production at concentrations in the range of 1.56 – 6.25 µg/ml but, at concentrations ≤
0.78 and ≥ 12.5 µg/ml, data showed a lack of caspase-3 activity. Similar
results were obtained in HT-1080 cells where Ag-NPs induce caspase-3
508
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production at concentrations in the range of 0.78 – 6.25 µg/ml whereas,
at concentrations ≤ 0.39 and ≥ 12.5 µg/ml caspase-3 activity was not
detected. Therefore, these findings could be explained by the presence
of a hormetic response.
Similar results were obtained by investigating the toxic effects of low
exposure levels of Ag-NPs (7 – 10 nm in diameter), stabilized with polyethylenimine, in human hepatoma derived cell line HepG2 (Kawata et al.
2009). To evaluate the cytotoxicity of Ag-NPs, cells were exposed for 24
hours to 0.1, 0.2, 0.5, 1.0, 1.5, 2.0, 2.5 and 3.0 mg/l of the nanoparticles.
At high exposure levels, the tested material exhibited a marked cytotoxicity. In fact, the cell viability of the HepG2 cells drastically decreased for
Ag-NP concentrations > 1 mg/l. Surprisingly, non-cytotoxic doses (0.1 –
0.5 mg/l) of the nanoparticles significantly increased the viability of
HepG2 cells. Hence, the low-dose stimulation and the high-dose inhibition of cell viability showed by the results of this study was interpreted by
the authors as being due to hormesis.
A study carried out in human bronchial epithelial BEAS 2B cells to
evaluate the cytotoxicity and genotoxicity of graphite nanofibers
obtained similar results (Lindberg et al. 2009). The nanomaterials were
dispersed in bronchial epithelial growth medium cell culture and subjected to ultrasonication for 20 min prior to addition to the cell cultures.
The viability of cells, exposed for 24, 48 and 72 h to eight doses (1, 5, 10,
20, 40, 60, 80 and 100 µg/cm2) of nanofibers was determined using the
Trypan blue dye exclusion technique by counting the number of living
cells under phase-contrast microscopy. In general, the number of viable
cells decreased with the incubation time, dropping to 50 % of the respective control value at about 10 – 40 µg/cm2 in the 24-h treatment and 40 –
60 µg/cm2 in the 48-h and 72-h treatment. However, interestingly, in the
24-h treatment a significant increase in the number of living cells was
observed at the lowest dose (1 µg/cm2). However, in the evaluation of viability of cell cultures exposed to CNTs or to carbon nanofibers, it is
important to note that these nanoparticles may show unexpected behaviour, such as aggregation or interference with optical measurements,
when routine in vitro assays are performed (Pfaller et al. 2010). These
interferences represent an important confounding factor because they
can be misinterpreted as cell death.
Finally, in a study performed to assess the efficacy of paclitaxel-loaded
in sterically stabilized, biocompatible and biodegradable sterically stabilized mixed phospholipid nanomicelles (P-SSMM) and of paclitaxel dissolved in dimethyl sulfoxide (P-DMSO) in circumventing the P-glycoprotein-mediated paclitaxel resistance in the human breast cancer cell line
BC19/3 revealed also the presence of a biphasic dose – response (Önyüksel et al. 2009). In fact, exposure of BC19/3 to P-SSMM and to P-DMSO
at concentrations in the range of 0.128 – 2000 ng/ml showed a slight
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increase in cell survival at the lower doses and a significant inhibition of
viability at concentrations exceeding 15 ng/ml.
IN VIVO STUDIES

A hormetic-like response has been also observed in diverse in vivo
studies (Table 2). In 2007, Roberts et al. (2007), while determining the
behaviour of a water-soluble, lysophophatidylcholine-coated single-walled
carbon nanotube (LPC-SWCNTs) in the presence of Daphnia magna, an
aquatic invertebrate, observed a typical biphasic dose-response. The
assessment of survival of Daphnia magna, exposed to 0.1, 0.25, 0.5, 1 and
2.5 mg/L of LPC-SWCNTs showed that the peak survival was reached at
an LPC-SWCNT concentration of 0.5 mg/L. At higher test concentrations, survival decreased in a dose-dependent manner as opposed to survival at concentrations below 0.5 mg/L in which survival increased in a
dose-dependent manner. On the basis of these findings, the authors suggested the presence of a hormetic response in which the organism gains
some benefit from low-level exposure, until a threshold concentration is
reached and toxicity occurs.
To evaluate the toxicity of nanosized titanium dioxide (TiO2),
Drobne et al. (2009) performed a laboratory single-species toxicity test
with the terrestrial arthropod (Porcellio scaber, Isopoda, Crustacea). The
isopods were exposed for 14 days to 10, 100 and 1000 µg/g dry food of
two different TiO2 nanoparticles (< 25 nm in diameter and < 75 nm in
diameter). The results of this study showed that there was a threshold-like
dose-dependent pattern for feeding parameters when animals were fed
on small nanosized TiO2, while when animals were exposed to larger
nano-TiO2 , no recognizable dose–response relationship pattern was
observed for feeding parameters. On the basis of previous work (Drobne
and Hopkin 1995), a reduction in feeding rate was expected as recorded
many times upon exposure to metal-dosed food but, contrary to expectations, nanosized TiO2 enhanced feeding rate. The authors suggested that
the increase in feeding parameters could be a hormetic-like response
which can have complex time response dynamics.
TiO2 nanoparticles of different sizes (10 and 30) were also used to
assess ecotoxicity to the freshwater green alga Pseudokirchneriella subcapitata (Hartmann et al. 2010). In particular, the authors assessed the growth
rate inhibition of algae by exposing them for 72 h to 16 concentrations
(0.6 – 250 mg/L) of several TiO2 nanoparticles. Nanoparticles stock solutions were prepared by suspending the TiO2 nanoparticles in algal test
medium in a concentration of 250 mg/L followed by 10 min sonication
in a water bath. These suspensions were sonicated again 10 min prior to
preparation of test suspensions. The results of this study showed a tendency of the smallest (10 nm) nanoparticles to induce higher inhibition
at lower concentrations. However, an extra data analysis, carried out
510
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Radish, rape and
ryegrass

Rape

Zinc and zinc oxide
nanoparticles

Cerium, lanthanum,
gadolinium and
ytterbium oxide
nanoparticles

To assess the
phytotoxicity of zinc and
zinc oxide nanoparticles

To evaluate the effects of
rare earth oxide
nanoparticles on root
elongation of plants

Ciliated protozoa
Tetrahymena thermophila

Freshwater green alga
Pseudokirchneriella
subcapitata

Titanium dioxide
nanoparticles

To evaluate the
ecotoxicity of three
different sizes of titanium
dioxide particles

Copper and zinc
nanoparticles

Terrestrial arthropod
Porcellio scaber, Isopoda,
Crustacea

Titanium dioxide
nanoparticles

To investigate the hazard
of titanium dioxide
nanoparticles

To evaluate the toxic
effects of two different
types of metal
nanoparticles

Acquatic invertebrate
Daphnia magna

Type of living organism

Water – soluble,
lysophophatidylcholine
coated single – walled
carbon nanotube
(LPC-SWCNTs)

Type of nanoparticles

To study the interactions
between an acquatic
invertebrate and a
water-soluble,
lysophophatidylcholine
coated single-walled
carbon nanotube

Aim of the study

TABLE 2. In vivo studies that showed a hormetic dose - response

0.2 – 2000 mg/L

0 – 2000 mg/L

Copper nanoparticles:
31.25 – 500 mg/L Zinc
nanoparticles: 1.85 – 25
mg/L

0.6 – 250 mg/L

10 – 1000 µg/g of dry
food

0.1 – 2.5 mg/L

Range of concentrations

At low concentrations (< 0.8 mg/L)
lanthanum and ytterbium
nanoparticles had positive effects on
root elongation but negative effects
at higher concentrations

Exposure to lower doses of
nanoparticles caused a slight
increase of root length whereas, root
growth was clearly restricted with
increasing concentration

At the lowest and sub-toxic
concentrations tested the
nanoparticles had a stimulatory
effect on ATP concentration of
Tetrahymena thermophila

Significant stimulation of the algal
growth rate at lower concentrations
and inhibition at higher doses.

Enhancement of the feeding rate

Low dose stimulation and high dose
inhibition of survival

Hormetic response References

Ma et al.
(2010)

Lin and Xing
(2007)

Mortimer et
al. (2010),

Hartmann et
al. (2010)
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using a three parameter log logistic curve fitting with a hormesis parameter added as described by Brain and Cousens (1989) and with a lack of
fit model as described by Cedergreen et al. (2005), revealed, for the larger nanoparticles (30 nm), a biphasic relationship with a statistically significant stimulation of the algal growth rate at lower concentrations and
an inhibition at higher doses.
Recently, a study by Mortimer et al. (2010), conducted on the ciliated
protozoa Tetrahymena thermophila exposed to 31.25, 62.5, 125, 250 and 500
mg/L of copper nanoparticles (Cu-NPs) and to 1.85, 5.55, 8.33, 12,5 and
25 of zinc nanoparticles (Zn-NPs) showed the presence of a hormetic
response. The toxic effects of these nanoparticles to protozoa were evaluated at two exposure times (4 and 24 h), using propidium iodide staining and cellular ATP concentration that are both correlated to the cell
viability. Interestingly, at the lowest and sub-toxic concentrations tested
(31.25 mg/L and 1.85 mg/L for Cu-NPs and Zn-NPs, respectively), the
nanoparticles had a stimulatory effect on ATP concentration of
Tetrahymena thermophila. The hormetic phenomenon was detected only by
the ATP measurements and not in the propidium iodide staining assay.
The assessment of the phytotoxicity of Zn-NPs (35 nm in diameter)
and zinc oxide nanoparticles (ZnO-NPs, 20 ± 5 nm in diameter) on seed
germination and root growth of radish, rape and ryegrass showed a
hormetic dose-response (Lin and Xing 2007). No significant root growth
inhibition was observed under low concentrations (less than 10 mg/L for
rape and ryegrass and 20 mg/L for radish). In particular, the exposure of
radish and rape to lower doses of ZnO-NPs and the exposure of ryegrass
to lower doses of Zn-NPs caused a slight increase in root length whereas,
root growth of these plant species was clearly restricted with increasing
concentration and was almost terminated at 200 mg/L.
Recently, a similar study, carried out by Ma et al. (2010), showed the
ability of other types of nanoparticles to induce a biphasic dose-response
relationship. As in the previous study, the phytotoxicity of cerium (CeO2NPs), lanthanum (La2O3-NPs), gadolinium (Gd2O3-NPs) and ytterbium
(Yb2O3-NPs) oxide nanoparticles was evaluated in several higher plant
species by means of root elongation experiments. The effects of exposure
to different concentrations (0.2 – 2000 mg/L) of rare earth oxide NPs on
root elongation of rape were particularly interesting. In fact, after exposure to La2O3-NPs and Yb2O3-NPs, root elongation in this plant was
enhanced at less than 0.8 mg/L but, as the concentration increased, root
growth was restricted and almost halted at 200 and 2000 mg/L.
Therefore, La2O3-NPs and Yb2O3-NPs had positive effects on root elongation at low concentrations (< 0.8 mg/L), but negative effects at higher
concentrations. The authors suggested that these findings could be
explained by “hormesis effects”.
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DISCUSSION AND CONCLUSION

The hormetic dose-response may be reliably described by a stimulation in the low dose zone and an inhibitory response at higher doses
(Calabrese 2009) The last three decades have witnessed growing interdisciplinary evidence of hormetic - biphasic dose-responses that are characterized by remarkably similar quantitative features of the dose-response
and similar underlying mechanistic explanatory strategies. It is the emergence and integration of these findings from diverse biomedical fields
that has led to consolidation of the hormesis dose- response concept
(Calabrese 2008a).
According to Stebbing’s theory, the key factor in the hormesis concept is not the chemical but, rather, the organism. In fact, the examples
gathered from the literature reviewed by Stebbing led him to suggest that
hormesis is not a specific effect of the agent that induces it, since it can
be induced by such a wide variety of agents of different kinds.
Furthermore, the ubiquity of hormesis that follows a similar pattern (beta
curve) in many taxa, suggests a common explanation. Therefore the
hypothesis tested was that hormesis is a consequence of an adaptive
response common to biological systems to the inhibitory effect that different agents have in common at higher concentrations (Stebbing, 1998).
In other words, the hormetic response is found in the organism’s overcompensation to a disruption in homeostasis (Stebbing 1987, 1998). If
this is the case, then any agent - even in nanoparticle form - that can disrupt homeostasis (i.e. cause toxicity) would be expected to induce a
hormetic response to the damage induced. The Stebbing theory does not
infer that all chemicals will be hormetic for all endpoints. It does, however, imply that biological systems respond in a hormetic manner to signals
that indicate stress, toxicity or disruptions in homeostasis (Calabrese
2008b).
In fact, the occurrence of hormetic dose-response in the toxicological
literature is extremely high and, to date, approximately 8000 doseresponses have been reported in the hormesis database (Calabrese and
Blain 2005). Nevertheless, to our knowledge, this review represents the
first attempt to summarize current data regarding the possible induction
of hormesis by nanoparticles.
In recent years, the number of studies that have investigated the
adverse health effects of nanoparticles has increased significantly because
the massive development of nanotechnologies has led to considerable
concern regarding the potential biological effects and human toxicity of
these materials. However, the toxicity of nanoparticles has not been fully
evaluated and, at present, there are many uncertainties as to whether the
unique properties of engineered nanoparticles also pose a health risk for
humans. These uncertainties arise because of gaps in knowledge about
the factors that are essential for predicting health risks such as the nature
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of the dose-response curve at low level exposures below the toxic threshold. In fact, most of the in vitro and in vivo studies that investigated and
identified several toxicological effects of CNTs, metal nanoparticles or
other nanomaterials used high doses of these chemicals, at exposure levels in excess of those encountered in the different environmental matrices or workplaces. Obviously, this feature represents a serious problem
when trying to detect the presence of a hormetic response. Toxicological
assessments that include either too few doses, too high doses or inadequate dose spacing are not capable of accurately assessing the nature of
the dose-response relationship. Consequently, using only high doses of
exposure, these studies might underestimate the occurrence of hormetic
responses.
Although, the Stebbing theory suggests that all chemicals have the
capacity to induce a hormetic response in some experimental settings, a
clear structural specificity exists in the induction of hormetic-like biphasic dose responses for specific endpoints and experimental conditions
(Calabrese 2008b). If this is true, then the contribution of the chemical
structure and composition of nanoparticles to the induction of hormesis
must be addressed very carefully since these materials are manipulated
on a near-atomic scale and their toxicological profiles may be quite different from those of larger particles with the same chemical composition
(NIOSH 2009). Furthermore, the toxicity of nanoparticles is not only
related to their chemical composition but there are several other parameters that must be taken into account. In fact, current evidence suggests
that the biological impact and the biokinetics of nanoparticles are
dependent on their small size (surface area and size distribution), chemical composition (purity, crystallinity, electronic properties, etc.), surface
structure (surface reactivity, surface groups, inorganic or organic coatings, etc.), solubility, shape, and aggregation (Nel et al. 2006). Hence, a
correct evaluation of the induction of a hormetic response by nanoparticles is not possible without a preliminary, accurate and precise characterization of these materials.
The hormetic dose-response must also be seen within a temporal context, that is, as a dose - time - response relationship. The reason for incorporating a temporal feature in hormesis is that it may also be described
as a modest overcompensation response following an initial disruption in
homeostasis, i.e. a type of rebound effect. The hormetic dose response
therefore represents the effects of a repair process that slightly or modestly overshoots the original homeostatic set point, resulting in the lowdose stimulatory response (Calabrese 1999, 2001). The assessment of the
dose response is therefore a dynamic process. Whereas harmful agents
may induce toxicity in affected biological systems, the organism or biological system is not a passive entity but will respond to damage signals
with a coordinated series of temporally- mediated repair processes. This
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dynamic aspect of toxicological assessment requires the inclusion of not
only a broad range of doses but also a series of temporal evaluations (i.e.
repeated measurements). Only by assessing the dose-response process
over time can an accurate assessment of the dose-response relationship
be determined, within which the hormetic dose response is best revealed
(Calabrese 2008b). Unfortunately, also in the studies that we have reported in this review the presence of a hormetic response was not evaluated
over time, therefore it would be of great interest to repeat these experiments using a series of temporal evaluations to better define the occurrence of hormesis.
In conclusion, the results of some studies that have investigated the
toxicological effects of the nanoparticles suggest that these chemicals
may be able to induce, in some experimental settings, a hormetic
response for specific endpoints. Nevertheless, the data currently available
on this topic are extremely limited and fragmentary and for this reason,
at the present time, it is not possible to reach comprehensive conclusions
or a broad consensus. Consequently, more research is needed on the
occurrence of the hormetic dose-response elicited by exposure to
nanoparticles. However, to be able to detect the real presence of hormesis, future studies should focus on deep and accurate characterization of
nanoparticles, they should use a broad range of exposure doses and also
include a series of temporal evaluations.
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